Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecules (Basel, Switzerland)|December 1, 2020
Specific Non-Reducing Ends in Heparins from Different Animal Origins: Building Blocks Analysis Using Reductive Amination Tagging by Sulfanilic AcidPierre A J MourierAnalytical Biochemistry|August 25, 2004
Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phasesPierre A J Mourier, Christian ViskovGlycoconjugate Journal|August 23, 2014
Antithrombin-binding oligosaccharides: structural diversities in a unique function?Marco Guerrini, Pierre A J Mourier, Giangiacomo Torri, et al.Journal of Pharmaceutical and Biomedical Analysis|August 8, 2016
Analytical comparison of a US generic enoxaparin with the originator product: The focus on comparative assessment of antithrombin-binding componentsPierre A J Mourier, Fréderic Herman, Philippe Sizun, et al.Journal of Pharmaceutical and Biomedical Analysis|May 15, 2012
Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signalPierre A J Mourier, Olivier Y Guichard, Fréderic Herman, et al.Journal of Pharmaceutical and Biomedical Analysis|October 12, 2010
Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signalPierre A J Mourier, Olivier Y Guichard, Fréderic Herman, et al.Analytical Biochemistry|February 25, 2014
Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparinPierre A J Mourier, Olivier Y Guichard, Frédéric Herman, et al.Molecules (Basel, Switzerland)|March 12, 2017
New Insights in Thrombin Inhibition Structure-Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight HeparinPierre A J Mourier, Olivier Y Guichard, Fréderic Herman, et al.Journal of Pharmaceutical and Biomedical Analysis|August 18, 2015
Analytical and statistical comparability of generic enoxaparins from the US market with the originator productPierre A J Mourier, Christophe Agut, Hajer Souaifi-Amara, et al.Pageof 1